Krystal Biotech, Inc.

Krystal Biotech, Inc.verified

KRYS

Price:

$185.97

Market Cap:

$5.35B

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syn...[Read more]

Industry

Biotechnology

IPO Date

2017-09-20

Stock Exchange

NASDAQ

Ticker

KRYS

The Enterprise Value as of December 2024 (TTM) for Krystal Biotech, Inc. (KRYS) is 4.98B

According to Krystal Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.98B. This represents a change of 13.71% compared to the average of 4.38B of the last 4 quarters.

Krystal Biotech, Inc. (KRYS) Historical Enterprise Value (quarterly & annually)

How has KRYS Enterprise Value performed in the past?

The mean historical Enterprise Value of Krystal Biotech, Inc. over the last ten years is 981.58M. The current 4.98B Enterprise Value has changed 50.59% with respect to the historical average. Over the past ten years (40 quarters), KRYS's Enterprise Value was at its highest in in the June 2024 quarter at 4.87B. The Enterprise Value was at its lowest in in the September 2017 quarter at -10864742.25.

Quarterly (TTM)
Annual

Average

981.58M

Median

783.43M

Minimum

6.80M

Maximum

3.02B

Krystal Biotech, Inc. (KRYS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Krystal Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.80%

Maximum Annual Enterprise Value = 3.02B

Minimum Annual Increase = -85.02%

Minimum Annual Enterprise Value = 6.80M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20233.02B61.72%
20221.87B53.06%
20211.22B40.08%
2020870.51M25.01%
2019696.35M439.26%
2018129.13M1.80%
20176.80M-85.02%

Krystal Biotech, Inc. (KRYS) Average Enterprise Value

How has KRYS Enterprise Value performed in the past?

The current Enterprise Value of Krystal Biotech, Inc. (KRYS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.03B

5-year avg

1.53B

10-year avg

981.58M

Krystal Biotech, Inc. (KRYS) Enterprise Value vs. Peers

How is KRYS’s Enterprise Value compared to its peers?

Krystal Biotech, Inc.’s Enterprise Value is greater than MeiraGTx Holdings plc (452.32M), greater than Apellis Pharmaceuticals, Inc. (4.38B), greater than Deciphera Pharmaceuticals, Inc. (2.15B), greater than REGENXBIO Inc. (488.21M), greater than Rhythm Pharmaceuticals, Inc. (3.65B),

Build a custom stock screener for Krystal Biotech, Inc. (KRYS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Krystal Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Krystal Biotech, Inc. (KRYS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Krystal Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Krystal Biotech, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Krystal Biotech, Inc. (KRYS)?

What is the 3-year average Enterprise Value for Krystal Biotech, Inc. (KRYS)?

What is the 5-year average Enterprise Value for Krystal Biotech, Inc. (KRYS)?

How does the current Enterprise Value for Krystal Biotech, Inc. (KRYS) compare to its historical average?